Supply Chain
South Korea and US top diplomats to hold talks amid Trump's tariff threat
Imeripotiwa na AI Picha iliyoundwa na AI
The top diplomats of South Korea and the United States will hold talks in Washington this week amid uncertainties over their trade deal following U.S. President Donald Trump's warning of a tariff hike. Foreign Minister Cho Hyun will meet one-on-one with U.S. Secretary of State Marco Rubio to discuss implementing summit agreements, including the trade deal. Cho is also attending a U.S.-led ministerial meeting on critical minerals supply chains.
A report by UK consultancy WTW identifies ongoing tariff wars and dependence on China as two top emerging risks for the global defence sector. It warns that the defence sector's reliance on Chinese materials and components, particularly rare earths and electronics, presents significant supply chain vulnerability amid geopolitical risks. The findings are based on interviews with five industry executives from Australia, Europe, and North America.
Imeripotiwa na AI
Following China's January 6 ban on dual-use exports to Japan—retaliation for Prime Minister Sanae Takaichi's Taiwan remarks—South Korea's industries face risks from interconnected supply chains. The Ministry of Trade, Industry and Resources held an emergency meeting on January 8 to evaluate impacts and pledged safeguards against shortages.
Tesla is urging its suppliers to eliminate China-sourced components from vehicles produced in the United States, amid escalating trade tensions. The company has already replaced several such parts and plans to complete the transition within one to two years. This shift reflects broader industry efforts to localize supply chains in response to tariff uncertainties.
Imeripotiwa na AI
Tesla is directing suppliers to exclude China-made components from vehicles built in the United States, according to reports. The company has already replaced some parts and plans to complete the transition within one to two years. This move accelerates amid escalating US-China trade tensions.
The PreCheck program was launched to boost domestic pharmaceutical manufacturing in the US. It focuses on increasing production capacity and supply chain resilience. Regulatory developments also include blood-based tests for Alzheimer's detection.